Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
23
results for
Pharmaceuticals
Filters
Refine your search
API developed for pharmaceutical injection formulations. It
is β-lactam enzyme inhibitor to treat upper and lower respiratory tract
infections. It is suitable for urinary tract infections, skin and soft tissue
infections. Benefits:
- Freely soluble in water
- Sterile as per Ph. Eur.
TDS
API designed for pharmaceutical injection formulations. It
is β-lactam enzyme inhibitor to treat upper and lower respiratory tract
infections. It is suitable for urinary tract infections, skin and soft tissue
infections. Benefits:
- Freely soluble in water
- Sterile as per Ph. Eur.
TDS
HEC Pharm
HEC Pharm Co., Ltd was established in 2003. It has passed US FDA and EUGMP inspections for many times. The main products are erythromycin thiocyanate, lincomycin, erythromycin base, azithromycin dihydrate and clarithromycin. HEC is the largest manufacturer of erythromycin thiocyanate in the world
Hubei Longxiang Pharmaceutical
"Hubei Longxiang Pharmaceutical Tech.Co.,Ltd., was established in 2002, with registered capital RMB123 million.
Now has 340 employees, total assets up to RMB440 million.
Longxiang is the GMP certified, Key national high-tech enterprise, China's top 10 manufacturer for veterinary APIs.
Specialized in R&D, producing and marketing of veterinary APIs and finished products.
Toltrazuril、Florfenicol、Tilmicosin、Valnemulin HCL and other more than 20 APIs, have been exported to more than 40 countries and areas, like Europe, South America, East Asia, Southeast Asia, Middle East."
Zhuhai United Laboratories
Founded in Hong Kong in 1990, The United Laboratories(TUL) is operating for over two decades, now TUL is positioned as one of the largest antibiotic pharmaceutical companies in the world. Considering that 100% of its capital is owned by Hong Kong Shareholders, TUL is currently structured into three Divisions: API and Intermediate Production, Biopharmaceutical products, Production formulation.
